Table 2. PATZ1 nuclear expression and sub-cellular localization.
| Hystotype | Nuclear anti-PATZ1 reactivity | PATZ1 sub-cellular localization | Negativea | ||||
|---|---|---|---|---|---|---|---|
| N. | (−) | (+) | Nuclear | Nucl/Cyt | Cytosol | ||
| FH | 4 | 0 | 4 (100%) | 4 (100%) | 0 | 0 | 0 |
| FL | 70 | 41 (59%) | 29 (41%) | 13 (19%) | 16 (23%) | 5 (7%) | 36 (51%) |
| DLBCL | 100 | 45 (45%) | 55 (55%) | 29 (29%) | 26 (26%) | 6 (6%) | 39 (39%) |
| -non GCB | 53 | 20 (38%) | 33 (62%) | 20 (38%) | 13 (24.5%) | 4 (7,5%) | 16 (30%) |
| -GCB | 47 | 25 (53%) | 22 (47%) | 9 (19%) | 13 (28%) | 2 (4%) | 23 (49%) |
a
PATZ1 expression absent in both nucleus and cytoplasm.